Evidence map›Paper›PMID 38879600›Full record

ArticleCell death & disease2024

Tripartite motif 8 promotes the progression of hepatocellular carcinoma via mediating ubiquitination of HNF1α.

Yu Peng, Hui Qian, Wen-Ping Xu, Meng-Chao Xiao, Chen-Hong Ding, Fang Liu, Huan-Yu Hong, Shu-Qing Liu, Xin Zhang, Wei-Fen Xie

Abstract read
In one paragraph

Article in Cell death & disease, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Blocking TRIM47-mediated HNF4Acta pharmaceutica Sinica. B · 2026
    Article
  2. Review
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Yu Peng *Department of Gastroenterology, Changzheng Hospital, Naval Medical University, Shanghai, China.
Hui Qian *Department of Gastroenterology, Changzheng Hospital, Naval Medical University, Shanghai, China.
Wen-Ping Xu *Department of Gastroenterology, Changzheng Hospital, Naval Medical University, Shanghai, China.
Meng-Chao XiaoDepartment of Gastroenterology, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai, China.
Chen-Hong DingDepartment of Gastroenterology, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai, China.
Fang LiuDepartment of Gastroenterology, Changzheng Hospital, Naval Medical University, Shanghai, China.
Huan-Yu HongDepartment of Gastroenterology, Changzheng Hospital, Naval Medical University, Shanghai, China.
Shu-Qing LiuDepartment of Gastroenterology, Changzheng Hospital, Naval Medical University, Shanghai, China.
Xin ZhangDepartment of Gastroenterology, Changzheng Hospital, Naval Medical University, Shanghai, China. zhang68@hotmail.com.
Wei-Fen XieDepartment of Gastroenterology, Changzheng Hospital, Naval Medical University, Shanghai, China. weifenxie@medmail.com.cn.ORCID 0000-0002-7137-112X

Funding

National Natural Science Foundation of China (National Science Foundation of China) 81870419
6 · The paper itself

Abstract

Tripartite motif 8 (TRIM8) is an E3 ligase that plays dual roles in various tumor types. The biological effects and underlying mechanism of TRIM8 in hepatocellular carcinoma (HCC) remain unknown. Hepatocyte nuclear factor 1α (HNF1α) is a key transcriptional factor that plays a significant role in regulating hepatocyte differentiation and liver function. The reduced expression of HNF1α is a critical event in the development of HCC, but the underlying mechanism for its degradation remains elusive. In this study, we discovered that the expression of TRIM8 was upregulated in HCC tissues, and was positively correlated with aggressive tumor behavior of HCC and shorter survival of HCC patients. Overexpression of TRIM8 promoted the proliferation, colony formation, invasion, and migration of HCC cells, while TRIM8 knockdown or knockout exerted the opposite effects. RNA sequencing revealed that TRIM8 knockout suppresses several cancer-related pathways, including Wnt/β-catenin and TGF-β signaling in HepG2 cells. TRIM8 directly interacts with HNF1α, promoting its degradation by catalyzing polyubiquitination on lysine 197 in HCC cells. Moreover, the cancer-promoting effects of TRIM8 in HCC were abolished by the HNF1α-K197R mutant in vitro and in vivo. These data demonstrated that TRIM8 plays an oncogenic role in HCC progression through mediating the ubiquitination of HNF1α and promoting its protein degradation, and suggests targeting TRIM8-HNF1α may provide a promising therapeutic strategy of HCC.

Indexed as

Carcinoma, HepatocellularDisease ProgressionHepatocyte Nuclear Factor 1-alphaLiver NeoplasmsUbiquitinationAnimalsCarrier ProteinsCell MovementCell ProliferationFemaleGene Expression Regulation, NeoplasticHep G2 CellsHumansMaleMiceMice, Inbred BALB CCarrier ProteinsHepatocyte Nuclear Factor 1-alphaHNF1A protein, humanNerve Tissue ProteinsTRIM8 protein, humanUbiquitin-Protein Ligases

Identifiers

PMID38879600
PMCPMC11180176

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.